Tech Company Financing Transactions
Lineagen Funding Round
Lineagen closed a $5 million Series A funding round on 8/30/2010. Investors included PrairieGold Venture Partners.
Transaction Overview
Company Name
Announced On
8/30/2010
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
PrairieGold Venture Partners (Michael Jerstad)
Proceeds Purpose
This latest close will support further development of Lineagen's lead autism program and the company's September 2010 commercial service launch.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2677 E Parleys Way
Salt Lake City, UT 84109
USA
Salt Lake City, UT 84109
USA
Phone
Website
Email Address
Overview
The company is developing a diagnostic platform that targets autism, multiple sclerosis, cancer and chronic obstructive pulmonary disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Paul
Vice President
Rena Vanzo
VP - Human Resources
Leanne Hill
VP - Operations
Mathew Harrison
VP - Sales
Jeffrey Knupp
Browse more venture capital transactions:
Prev: 8/30/2010: Gliknik venture capital transaction
Next: 8/30/2010: ZOZI venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs